Company profile VYNE
After 39 days of this quarter the interest is at 13.0. Based on that we can calculate that during remaining 52 days it will total up to 30.0. VYNE Therapeutics expected interest is significantly higher compared to previous quarter (+130.8%) and same quarter last year (+400.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 24 | 0 -100.0% QoQ | 17 inf% QoQ | 6 -64.7% QoQ |
| 2020 | 11 -54.2% YoY 83.3% QoQ | 13 inf% YoY 18.2% QoQ | 35 105.9% YoY 169.2% QoQ | 64 966.7% YoY 82.9% QoQ |
| 2021 | 380 3354.5% YoY 493.8% QoQ | 81 523.1% YoY -78.7% QoQ | 79 125.7% YoY -2.5% QoQ | 69 7.8% YoY -12.7% QoQ |
| 2022 | 46 -87.9% YoY -33.3% QoQ | 27 -66.7% YoY -41.3% QoQ | 14 -82.3% YoY -48.1% QoQ | 18 -73.9% YoY 28.6% QoQ |
| 2023 | 6 -87.0% YoY -66.7% QoQ | 24 -11.1% YoY 300.0% QoQ | 28 100.0% YoY 16.7% QoQ | 13 -27.8% YoY -53.6% QoQ |
| 2024 | 13 116.7% YoY 0.0% QoQ | - | - | - |
The average 5 years interest of VYNE Therapeutics was 3.71 per week. The last year interest of VYNE Therapeutics compared to the last 5 years has changed by -59.57%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 38.89%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. VYNE Therapeutics stock expected interest is significantly lower compared to previous quarter (-100.0%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 5 | 27 440.0% QoQ | 14 -48.1% QoQ | 11 -21.4% QoQ |
| 2020 | 32 540.0% YoY 190.9% QoQ | 9 -66.7% YoY -71.9% QoQ | 31 121.4% YoY 244.4% QoQ | 48 336.4% YoY 54.8% QoQ |
| 2021 | 353 1003.1% YoY 635.4% QoQ | 50 455.6% YoY -85.8% QoQ | 65 109.7% YoY 30.0% QoQ | 51 6.2% YoY -21.5% QoQ |
| 2022 | 9 -97.5% YoY -82.4% QoQ | 30 -40.0% YoY 233.3% QoQ | 33 -49.2% YoY 10.0% QoQ | 17 -66.7% YoY -48.5% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 23 -23.3% YoY inf% QoQ | 48 45.5% YoY 108.7% QoQ | 6 -64.7% YoY -87.5% QoQ |
| 2024 | 0 -64.7% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of VYNE Therapeutics stock was 3.3 per week. The last year interest of VYNE Therapeutics stock compared to the last 5 years has changed by -55.15%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -2.63%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. VYNE Therapeutics news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 42 | 59 40.5% QoQ | 109 84.7% QoQ | 118 8.3% QoQ |
| 2020 | 249 492.9% YoY 111.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 71 -34.9% YoY inf% QoQ | 49 -58.5% YoY -31.0% QoQ |
| 2021 | 304 22.1% YoY 520.4% QoQ | 27 inf% YoY -91.1% QoQ | 65 -8.5% YoY 140.7% QoQ | 133 171.4% YoY 104.6% QoQ |
| 2022 | 45 -85.2% YoY -66.2% QoQ | 98 263.0% YoY 117.8% QoQ | 65 0.0% YoY -33.7% QoQ | 85 -36.1% YoY 30.8% QoQ |
| 2023 | 111 146.7% YoY 30.6% QoQ | 108 10.2% YoY -2.7% QoQ | 81 24.6% YoY -25.0% QoQ | 162 90.6% YoY 100.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of VYNE Therapeutics news was 7.59 per week. The last year interest of VYNE Therapeutics news compared to the last 5 years has changed by -3.69%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -5.43%.
There is not enough data for VYN201 to provide analysis
There is not enough data for VYN201 to provide correlation calculation
There is not enough data for VYN201 to provide analysis
There is not enough data for VYN202 to provide analysis
There is not enough data for VYN202 to provide correlation calculation
There is not enough data for VYN202 to provide analysis
There is not enough data for FMX114 to provide analysis
There is not enough data for FMX114 to provide correlation calculation
There is not enough data for FMX114 to provide analysis
There is not enough data for VYNE Therapeutics address to provide analysis
There is not enough data for VYNE Therapeutics address to provide correlation calculation
There is not enough data for VYNE Therapeutics address to provide analysis
There is not enough data for VYNE Therapeutics CEO to provide analysis
There is not enough data for VYNE Therapeutics CEO to provide correlation calculation
There is not enough data for VYNE Therapeutics CEO to provide analysis
There is not enough data for VYNE Therapeutics products to provide analysis
There is not enough data for VYNE Therapeutics products to provide correlation calculation
There is not enough data for VYNE Therapeutics products to provide analysis